Skip to main content

Advertisement

Log in

Comment on: “Autoimmune uveitis: clinical, pathogenetic, and therapeutic features”

  • Letter to the Editor
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Prete M, Dammacco R, Fatone MC, Racanelli V. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. Clin Exp Med. 2015. doi:10.1007/s10238-015-0345-6

    PubMed  Google Scholar 

  2. Ayyıldız O, Durukan AH, Ozgurtas T, Gunal A. A Comparison of intravitreal bevacizumab and steroid activity in an experimental uveitis model. Curr Eye Res. 2015;40(12):1261–8.

    Article  PubMed  Google Scholar 

  3. Egwuagu CE, Sun L, Kim SH, Dambuza IM. Ocular inflammatory diseases: molecular pathogenesis and ımmunotherapy. Curr Mol Med. 2015;15(6):517–28.

    Article  CAS  PubMed  Google Scholar 

  4. Tomkins-Netzer O, Lightman S, Drye L, Multicenter Uveitis Steroid Treatment Trial Research Group, et al. Outcome of treatment of uveitic macular edema: the multicenter uveitis steroid treatment trial 2-year results. Ophthalmology. 2015;122(11):2351–9.

    Article  PubMed  Google Scholar 

  5. Lardenoye CWTA, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113(8):1446–9.

    Article  PubMed  Google Scholar 

  6. Al-Dhibi H, Hamade IH, Al-Halafi A, et al. The effects of ıntravitreal bevacizumab in infectious and noninfectious uveitic macular edema. J Ophthalmol. 2014;2014:729465.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Neri P, Mariotti C, Cimino L, et al. Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. Int Ophthalmol. 2009;29(3):127–33.

    Article  PubMed  Google Scholar 

  8. Schilling H, Heiligenhaus A, Laube T, et al. Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation. Retina. 2005;25(2):182–8.

    Article  PubMed  Google Scholar 

  9. Papadaki T, Zacharopoulos I, Iaccheri B, et al. Somatostatin for uveitic cystoid macular edema (CME). Ocul Immunol Inflamm. 2005;13(6):469–70.

    Article  CAS  PubMed  Google Scholar 

  10. Deuter CME, Kötter I, Günaydin I, et al. Efficacy and tolerability of journal of ophthalmology interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol. 2009;93(7):906–13.

    Article  CAS  PubMed  Google Scholar 

  11. Cordero-Coma M, Sobrin L. Anti-tumor necrosis factor-α therapy in uveitis. Surv Ophthalmol. 2015;60(6):575–89.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gokhan Ozge.

Ethics declarations

Conflict of interest

The authors have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ozge, G., Kucukevcilioglu, M. & Koylu, M.T. Comment on: “Autoimmune uveitis: clinical, pathogenetic, and therapeutic features”. Clin Exp Med 16, 137–138 (2016). https://doi.org/10.1007/s10238-016-0415-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-016-0415-4

Keywords

Navigation